| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | N2UJM5NBF6 |
| InChI Key | DTXXSJZBSTYZKE-ZDQKKZTESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H42O4 |
| Molecular Weight | 418.62 |
| AlogP | 4.69 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 69.92 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 30.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 1
|
1-160 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperparathyroidism, Secondary | 3 | D006962 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 103909-75-7 |
| ChEBI | 31801 |
| ChEMBL | CHEMBL333950 |
| DrugCentral | 1638 |
| EPA CompTox | DTXSID4048648 |
| FDA SRS | N2UJM5NBF6 |
| Guide to Pharmacology | 2784 |
| PDB | MCZ |
| PubChem | 6398761 |
| SureChEMBL | SCHEMBL17975926 |
| ZINC | ZINC000004474617 |